Novo Nordisk 20 avr. 2026 Novo Nordisk to seek oral sickle cell therapy approval after Phase III victory - Yahoo
Novo Nordisk 20 avr. 2026 Novo Nordisk Details Progress of DKK 15 Billion Share Buyback Programme - TipRanks
Novo Nordisk 20 avr. 2026 Novo readies SCD drug from $1.1B Forma buyout for approval push after phase 3 win - Fierce Biotech
Novo Nordisk 20 avr. 2026 Novo posts trial win for sickle cell disease drug (NVO:NYSE) - Seeking Alpha
Novo Nordisk 17 avr. 2026 Eli Lilly's Pill Lags Novo Nordisk's In First Week. Why Stock Rallied. - Investor's Business Daily
FierceBiotech 1 avr. 2026 KBP hopes to revive troubled heart drug at center of deal fraud dispute with Novo Nordisk
FierceBiotech 25 mars 2026 Novo Nordisk prepares to go global as triple-G prospect passes midphase diabetes test in China
FierceBiotech 12 mars 2026 Novo Holdings sees assets shrink by a 3rd in wake of Novo Nordisk's nosediving share price
Endpoints News 12 mars 2026 Novo Holdings’ assets fell by a third in 2025 as Novo Nordisk’s value sank
Endpoints News 27 févr. 2026 Novo Nordisk’s ‘strategic conundrum’: How being anchored to the past could cost it the future
FierceBiotech 25 févr. 2026 Novo Nordisk inks $2.1B pact with Langer startup to boost oral drug delivery prowess